id
string | patient_id
string | cardiotoxicity_risk_score
float64 | risk_category
string | ct_paths
sequence | ecg_paths
sequence | clinical_notes
string | age
int64 | gender
string | heart_failure
int64 | atrial_fibrillation
int64 | hypertension
int64 | diabetes
int64 | chemotherapy_history
int64 | radiotherapy_dose
float64 | anthracycline_dose
float64 | trastuzumab_history
int64 | systolic_bp
int64 | diastolic_bp
int64 | heart_rate
int64 | respiratory_rate
int64 | temperature
float64 | troponin
float64 | bnp
int64 | creatinine
float64 | rt_total_dose_gy
float64 | rt_fraction_size_gy
float64 | rt_heart_mean_dose_gy
float64 | rt_heart_max_dose_gy
float64 | rt_left_ventricle_mean_dose_gy
float64 | rt_left_ventricle_max_dose_gy
float64 | rt_v5_heart_percent
float64 | rt_v10_heart_percent
float64 | rt_v20_heart_percent
float64 | rt_v30_heart_percent
float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
imp_644176
|
p16540001
| 17.5
|
Very High
|
[
"files/p16540001/p165400017907/s30704878/",
"files/p16540001/p165400011262/s64506494/",
"files/p16540001/p165400014223/s27593505/"
] |
[
"p1654/p16540001/s41213324",
"p1654/p16540001/s44612456",
"p1654/p16540001/s49023381",
"p1654/p16540001/s49150286",
"p1654/p16540001/s49390303",
"p1654/p16540001/s49892033"
] |
Patient p16540001 is a 64-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 64
|
F
| 1
| 1
| 1
| 1
| 0
| 7.1
| 216
| 1
| 117
| 98
| 61
| 16
| 37.5
| 2.6
| 3,182
| 1.06
| 15.7
| 2.6
| 4
| 15.7
| 10.1
| 8.9
| 52
| 4
| 6.5
| 7.2
|
imp_799984
|
p16540161
| 20
|
Very High
|
[
"files/p16540161/p165401616996/s18440661/",
"files/p16540161/p165401616982/s77641423/"
] |
[
"p1654/p16540161/s44513733",
"p1654/p16540161/s46110312"
] |
Patient p16540161 is a 64-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 64
|
F
| 1
| 1
| 1
| 1
| 0
| 48.4
| 473.3
| 1
| 111
| 73
| 62
| 13
| 36.8
| 2.25
| 3,575
| 0.71
| 64.9
| 2.4
| 20.5
| 12
| 19
| 23.6
| 24.4
| 24.9
| 1.9
| 12.7
|
imp_501171
|
p16540182
| 18
|
Very High
|
[
"files/p16540182/p165401827135/s19530298/"
] |
[
"p1654/p16540182/s41075636",
"p1654/p16540182/s41683925",
"p1654/p16540182/s41815674",
"p1654/p16540182/s42391181",
"p1654/p16540182/s44795633",
"p1654/p16540182/s46581393",
"p1654/p16540182/s46955050",
"p1654/p16540182/s48136273",
"p1654/p16540182/s48868628",
"p1654/p16540182/s49272469",
"p1654/p16540182/s49418787",
"p1654/p16540182/s49988627"
] |
Patient p16540182 is a 90-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 90
|
F
| 1
| 1
| 1
| 1
| 0
| 6.1
| 121.5
| 1
| 133
| 106
| 69
| 24
| 36.2
| 4.62
| 3,228
| 1.32
| 47.1
| 2
| 16.9
| 38.3
| 11
| 33.7
| 23.8
| 4.2
| 17.3
| 1.6
|
imp_144146
|
p16540184
| 16
|
Very High
|
[
"files/p16540184/p165401842111/s10586267/"
] |
[
"p1654/p16540184/s40742253",
"p1654/p16540184/s42048210"
] |
Patient p16540184 is a 71-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 71
|
M
| 0
| 1
| 1
| 1
| 0
| 16.1
| 199.3
| 1
| 136
| 82
| 111
| 15
| 37.1
| 3.7
| 2,314
| 1.13
| 36.6
| 2.8
| 3.8
| 9.1
| 14.3
| 13.6
| 40.1
| 29.6
| 3.6
| 6.1
|
imp_730888
|
p16540200
| 23.5
|
Very High
|
[
"files/p16540200/p165402002477/s40923692/",
"files/p16540200/p165402009143/s66795633/"
] |
[
"p1654/p16540200/s45719634",
"p1654/p16540200/s48643560"
] |
Patient p16540200 is a 82-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 82
|
F
| 1
| 1
| 0
| 1
| 1
| 60.3
| 591.2
| 0
| 128
| 94
| 114
| 19
| 38.2
| 1.2
| 3,820
| 1.98
| 29.7
| 3
| 2
| 32.1
| 8.1
| 33.9
| 32
| 25
| 10.1
| 12.5
|
imp_213034
|
p16540288
| 14.5
|
Very High
|
[
"files/p16540288/p165402887934/s52417283/"
] |
[
"p1654/p16540288/s41023446",
"p1654/p16540288/s41173345",
"p1654/p16540288/s41232297",
"p1654/p16540288/s43369301",
"p1654/p16540288/s43399440",
"p1654/p16540288/s43493286",
"p1654/p16540288/s43710346",
"p1654/p16540288/s43812437",
"p1654/p16540288/s44829012",
"p1654/p16540288/s45397792",
"p1654/p16540288/s45533966",
"p1654/p16540288/s46083508",
"p1654/p16540288/s46188888",
"p1654/p16540288/s46504415",
"p1654/p16540288/s46520146",
"p1654/p16540288/s46523329",
"p1654/p16540288/s47517493",
"p1654/p16540288/s47638802",
"p1654/p16540288/s48211454",
"p1654/p16540288/s48377641"
] |
Patient p16540288 is a 51-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 51
|
M
| 0
| 1
| 1
| 0
| 1
| 14.8
| 485.6
| 0
| 145
| 85
| 90
| 20
| 38.1
| 3.11
| 3,895
| 1.34
| 47.7
| 2.8
| 23.4
| 26.4
| 7.1
| 33.2
| 13
| 36.9
| 21
| 3.6
|
imp_719019
|
p16540289
| 11.5
|
High
|
[
"files/p16540289/p165402899627/s56554895/"
] |
[
"p1654/p16540289/s40095348",
"p1654/p16540289/s44729290",
"p1654/p16540289/s46596590",
"p1654/p16540289/s47812800",
"p1654/p16540289/s48926150",
"p1654/p16540289/s49909037"
] |
Patient p16540289 is a 33-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 33
|
F
| 0
| 1
| 1
| 0
| 1
| 12.2
| 102.4
| 0
| 103
| 71
| 90
| 22
| 37.2
| 1.15
| 3,417
| 2.47
| 63.6
| 1.9
| 18.8
| 13.8
| 14.6
| 33.4
| 24.9
| 29.6
| 14.2
| 3.1
|
imp_978922
|
p16540310
| 15.5
|
Very High
|
[
"files/p16540310/p165403102013/s86783494/",
"files/p16540310/p165403103112/s60119541/"
] |
[
"p1654/p16540310/s40235839"
] |
Patient p16540310 is a 42-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 42
|
F
| 0
| 1
| 1
| 0
| 0
| 37.7
| 329.8
| 0
| 93
| 93
| 114
| 13
| 37.3
| 1.98
| 4,087
| 2.93
| 16
| 2.3
| 9.9
| 21.3
| 9.7
| 15.1
| 20.6
| 16.9
| 17.3
| 6
|
imp_932149
|
p16540501
| 18
|
Very High
|
[
"files/p16540501/p165405015951/s44314112/"
] |
[
"p1654/p16540501/s40392171"
] |
Patient p16540501 is a 88-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 88
|
M
| 0
| 1
| 1
| 1
| 0
| 25.8
| 499.8
| 1
| 146
| 81
| 109
| 20
| 37.7
| 0.15
| 1,362
| 1.4
| 32.3
| 2.8
| 19.6
| 23.5
| 15.7
| 30.1
| 7.9
| 11
| 22.8
| 13.1
|
imp_773896
|
p16540576
| 12
|
Very High
|
[
"files/p16540576/p165405765018/s38076848/"
] |
[
"p1654/p16540576/s48641614"
] |
Patient p16540576 is a 90-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 90
|
F
| 0
| 0
| 0
| 0
| 0
| 27
| 196.9
| 0
| 109
| 65
| 61
| 13
| 38.8
| 2.11
| 3,083
| 2.96
| 11.8
| 2.2
| 18.8
| 22.8
| 17.1
| 24.3
| 6
| 24.8
| 3.4
| 8.7
|
imp_203365
|
p16540581
| 19.5
|
Very High
|
[
"files/p16540581/p165405816039/s53808298/",
"files/p16540581/p165405815347/s69369552/",
"files/p16540581/p165405817150/s17598656/"
] |
[
"p1654/p16540581/s46741070",
"p1654/p16540581/s46762385",
"p1654/p16540581/s48156918",
"p1654/p16540581/s48610124"
] |
Patient p16540581 is a 34-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 34
|
F
| 1
| 1
| 0
| 1
| 0
| 56.7
| 312.2
| 1
| 162
| 87
| 96
| 14
| 38.3
| 4.51
| 3,794
| 0.65
| 46.4
| 2.8
| 11.5
| 23.8
| 2.1
| 4.3
| 21.6
| 36.9
| 16
| 13.8
|
imp_703587
|
p16540765
| 15.5
|
Very High
|
[
"files/p16540765/p165407654502/s59038710/",
"files/p16540765/p165407656240/s23029027/"
] |
[
"p1654/p16540765/s42702374",
"p1654/p16540765/s46326976"
] |
Patient p16540765 is a 85-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 85
|
M
| 0
| 1
| 1
| 1
| 0
| 1.2
| 484.1
| 1
| 112
| 66
| 82
| 16
| 39
| 0.24
| 3,137
| 1.06
| 26.8
| 2.4
| 24.9
| 25.3
| 3.4
| 27.8
| 40.4
| 10.8
| 15.4
| 1.1
|
imp_199524
|
p16540773
| 18
|
Very High
|
[
"files/p16540773/p165407731891/s72751921/",
"files/p16540773/p165407738540/s52858123/",
"files/p16540773/p165407732309/s26523308/"
] |
[
"p1654/p16540773/s40105496",
"p1654/p16540773/s40702765",
"p1654/p16540773/s41689231",
"p1654/p16540773/s43976037",
"p1654/p16540773/s44066796",
"p1654/p16540773/s45337219",
"p1654/p16540773/s45360001",
"p1654/p16540773/s45514224",
"p1654/p16540773/s45579640",
"p1654/p16540773/s48242901"
] |
Patient p16540773 is a 88-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 88
|
F
| 1
| 0
| 1
| 0
| 0
| 61.8
| 504.1
| 1
| 108
| 63
| 92
| 17
| 38.4
| 0.32
| 69
| 2.8
| 40.7
| 1.9
| 24.6
| 20.9
| 16.3
| 17.2
| 34.3
| 39.6
| 9.5
| 5.6
|
imp_223179
|
p16540839
| 17
|
Very High
|
[
"files/p16540839/p165408399708/s80425765/",
"files/p16540839/p165408398122/s63399815/",
"files/p16540839/p165408397629/s50311520/"
] |
[
"p1654/p16540839/s47807350"
] |
Patient p16540839 is a 89-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 89
|
M
| 1
| 0
| 0
| 1
| 0
| 25.9
| 194.3
| 0
| 155
| 110
| 54
| 15
| 36.4
| 3.44
| 1,017
| 2.71
| 51.1
| 2.4
| 10.2
| 38.3
| 16
| 32.9
| 10.2
| 19
| 20.5
| 5.4
|
imp_901144
|
p16540863
| 18
|
Very High
|
[
"files/p16540863/p165408638039/s38831052/",
"files/p16540863/p165408637362/s54304966/",
"files/p16540863/p165408634851/s26516208/"
] |
[
"p1654/p16540863/s41955001",
"p1654/p16540863/s43909196",
"p1654/p16540863/s44318798"
] |
Patient p16540863 is a 77-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 77
|
M
| 0
| 1
| 0
| 0
| 1
| 69.5
| 112.6
| 1
| 170
| 83
| 92
| 22
| 37.6
| 2.06
| 4,868
| 2.43
| 34.9
| 2.1
| 22.5
| 8.7
| 14.6
| 24.1
| 27
| 10.8
| 3.4
| 8.3
|
imp_350205
|
p16540866
| 14
|
Very High
|
[
"files/p16540866/p165408669108/s53254231/"
] |
[
"p1654/p16540866/s46003209"
] |
Patient p16540866 is a 60-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 60
|
F
| 0
| 0
| 0
| 0
| 1
| 5.9
| 538.9
| 0
| 158
| 78
| 72
| 12
| 36.2
| 3.23
| 4,836
| 2.18
| 40.8
| 1.8
| 4
| 13
| 7.2
| 19.4
| 46
| 10.2
| 8.6
| 10.5
|
imp_478222
|
p16540883
| 13
|
Very High
|
[
"files/p16540883/p165408838536/s94181529/",
"files/p16540883/p165408839961/s63148619/"
] |
[
"p1654/p16540883/s43914935"
] |
Patient p16540883 is a 67-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 67
|
F
| 0
| 0
| 0
| 0
| 1
| 44.6
| 289.7
| 0
| 176
| 88
| 99
| 20
| 39
| 2.65
| 3,277
| 1.25
| 39.7
| 2.1
| 24.6
| 15.4
| 11.3
| 6.6
| 51.9
| 4.3
| 12.9
| 8.8
|
imp_708302
|
p16540899
| 19.5
|
Very High
|
[
"files/p16540899/p165408998679/s60231698/"
] |
[
"p1654/p16540899/s40285063",
"p1654/p16540899/s43644264",
"p1654/p16540899/s45200414",
"p1654/p16540899/s48657281"
] |
Patient p16540899 is a 93-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 93
|
M
| 1
| 1
| 1
| 1
| 1
| 28.6
| 399.6
| 1
| 111
| 76
| 92
| 14
| 38.3
| 0.14
| 4,917
| 1.01
| 65.6
| 2.5
| 19.1
| 25.9
| 17
| 17.3
| 38
| 11.3
| 21.9
| 7.3
|
imp_805282
|
p16540985
| 15.5
|
Very High
|
[
"files/p16540985/p165409854979/s34928985/"
] |
[
"p1654/p16540985/s44627892"
] |
Patient p16540985 is a 19-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 19
|
M
| 0
| 1
| 1
| 1
| 1
| 36.7
| 153.5
| 1
| 125
| 78
| 58
| 18
| 36.4
| 0.87
| 2,029
| 2.94
| 43.4
| 2.8
| 4.1
| 43.9
| 16.7
| 34.7
| 33.8
| 5.7
| 7.9
| 1
|
imp_843760
|
p16541161
| 17.5
|
Very High
|
[
"files/p16541161/p165411618766/s74192137/",
"files/p16541161/p165411619881/s21905405/",
"files/p16541161/p165411615003/s45615910/"
] |
[
"p1654/p16541161/s42304035"
] |
Patient p16541161 is a 88-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 88
|
F
| 1
| 1
| 1
| 1
| 0
| 38.1
| 44.2
| 0
| 104
| 105
| 87
| 25
| 38.4
| 0.97
| 46
| 2.46
| 43.7
| 2.6
| 8.3
| 10.1
| 12.6
| 10.2
| 26.5
| 31.8
| 17
| 4.6
|
imp_733136
|
p16541213
| 18.5
|
Very High
|
[
"files/p16541213/p165412132642/s96219997/"
] |
[
"p1654/p16541213/s40318734",
"p1654/p16541213/s42593667",
"p1654/p16541213/s44806494",
"p1654/p16541213/s44966460",
"p1654/p16541213/s45665577",
"p1654/p16541213/s46241822",
"p1654/p16541213/s47175320",
"p1654/p16541213/s48933368",
"p1654/p16541213/s49048880",
"p1654/p16541213/s49500605"
] |
Patient p16541213 is a 58-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 58
|
F
| 1
| 1
| 1
| 0
| 1
| 56.5
| 204
| 1
| 117
| 83
| 54
| 21
| 36.5
| 1.31
| 2,884
| 1
| 45.9
| 2.5
| 10.7
| 6.1
| 17
| 34.3
| 7.9
| 39.7
| 13.2
| 6.1
|
imp_542320
|
p16541253
| 18.5
|
Very High
|
[
"files/p16541253/p165412533686/s34911963/",
"files/p16541253/p165412536896/s13427039/",
"files/p16541253/p165412539009/s68047375/"
] |
[
"p1654/p16541253/s43714136"
] |
Patient p16541253 is a 68-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 68
|
M
| 0
| 1
| 1
| 1
| 1
| 64.2
| 406.3
| 1
| 159
| 105
| 94
| 13
| 38.3
| 0.06
| 4,110
| 1.88
| 23.2
| 2.1
| 23.5
| 36.4
| 17.3
| 29.1
| 46.2
| 33.8
| 13.1
| 0.7
|
imp_954886
|
p16541420
| 20
|
Very High
|
[
"files/p16541420/p165414204107/s39127109/"
] |
[
"p1654/p16541420/s42305841"
] |
Patient p16541420 is a 95-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 95
|
M
| 0
| 0
| 1
| 1
| 1
| 37.4
| 445.3
| 1
| 161
| 99
| 100
| 24
| 36.6
| 2.46
| 1,934
| 2.84
| 60.8
| 2.7
| 2.2
| 28.6
| 7.9
| 29.3
| 46.9
| 9.8
| 7
| 3.6
|
imp_512871
|
p16541550
| 19.5
|
Very High
|
[
"files/p16541550/p165415508848/s91027831/"
] |
[
"p1654/p16541550/s42894309",
"p1654/p16541550/s44853142",
"p1654/p16541550/s45675687"
] |
Patient p16541550 is a 34-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 34
|
F
| 1
| 1
| 1
| 0
| 0
| 67.1
| 355.8
| 1
| 178
| 93
| 95
| 15
| 36.8
| 3.19
| 4,012
| 1.25
| 46.1
| 2.9
| 6.6
| 20.6
| 2.2
| 14.7
| 17.9
| 37.8
| 22.7
| 11.7
|
imp_853180
|
p16541709
| 10.5
|
High
|
[
"files/p16541709/p165417094446/s27886045/"
] |
[
"p1654/p16541709/s40274640",
"p1654/p16541709/s41828002",
"p1654/p16541709/s43296909",
"p1654/p16541709/s44428617",
"p1654/p16541709/s46681058",
"p1654/p16541709/s46911118",
"p1654/p16541709/s48460275",
"p1654/p16541709/s48602933",
"p1654/p16541709/s48822259",
"p1654/p16541709/s49863273"
] |
Patient p16541709 is a 24-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 24
|
M
| 0
| 0
| 0
| 0
| 0
| 55
| 446.9
| 1
| 118
| 74
| 75
| 21
| 38.1
| 3.74
| 995
| 0.74
| 10.9
| 2.5
| 17
| 15.8
| 12.1
| 6.3
| 49
| 23.5
| 17.8
| 7.6
|
imp_880465
|
p16542086
| 15.5
|
Very High
|
[
"files/p16542086/p165420865736/s64341068/",
"files/p16542086/p165420861654/s44772628/",
"files/p16542086/p165420863185/s34970308/"
] |
[
"p1654/p16542086/s41799992",
"p1654/p16542086/s43520936",
"p1654/p16542086/s45192660",
"p1654/p16542086/s45592232",
"p1654/p16542086/s45636470",
"p1654/p16542086/s46047745",
"p1654/p16542086/s49057607"
] |
Patient p16542086 is a 37-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 37
|
F
| 0
| 1
| 1
| 0
| 1
| 59.8
| 361.4
| 1
| 97
| 89
| 61
| 18
| 36.6
| 4.63
| 4,713
| 1.11
| 55.8
| 2.1
| 21.1
| 39.8
| 4.3
| 17.5
| 5.8
| 8.1
| 20.5
| 7.7
|
imp_141801
|
p16542549
| 20
|
Very High
|
[
"files/p16542549/p165425493684/s42222061/",
"files/p16542549/p165425498539/s62986889/"
] |
[
"p1654/p16542549/s40754486",
"p1654/p16542549/s48539412",
"p1654/p16542549/s49127906"
] |
Patient p16542549 is a 86-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 86
|
F
| 1
| 0
| 0
| 1
| 1
| 46.5
| 197.4
| 1
| 111
| 94
| 69
| 21
| 36.7
| 2.14
| 1,076
| 2.92
| 16.5
| 2.4
| 10.8
| 41
| 18.3
| 28.5
| 21.2
| 22.8
| 21.6
| 11.7
|
imp_464175
|
p16542611
| 14.5
|
Very High
|
[
"files/p16542611/p165426114061/s92854148/",
"files/p16542611/p165426113708/s44666735/"
] |
[
"p1654/p16542611/s40145789",
"p1654/p16542611/s45402679"
] |
Patient p16542611 is a 42-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 42
|
F
| 1
| 0
| 0
| 1
| 1
| 3.2
| 6.2
| 1
| 91
| 63
| 82
| 18
| 37.3
| 1.32
| 1,649
| 2.71
| 36.7
| 2.7
| 23.7
| 21
| 6
| 7.9
| 26
| 6.5
| 17.8
| 14.2
|
imp_778521
|
p16542621
| 16
|
Very High
|
[
"files/p16542621/p165426214879/s73538371/",
"files/p16542621/p165426213612/s93476643/"
] |
[
"p1654/p16542621/s46003318"
] |
Patient p16542621 is a 61-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 61
|
M
| 1
| 0
| 1
| 1
| 0
| 1.8
| 200.7
| 0
| 175
| 88
| 91
| 17
| 38.8
| 2.46
| 1,412
| 2
| 66.9
| 2.7
| 20.8
| 10.2
| 2.6
| 26.7
| 32.8
| 24.3
| 8.7
| 4.1
|
imp_926420
|
p16542622
| 9.5
|
High
|
[
"files/p16542622/p165426226540/s81795409/"
] |
[
"p1654/p16542622/s45852025"
] |
Patient p16542622 is a 35-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 35
|
F
| 0
| 0
| 1
| 0
| 0
| 3
| 271.5
| 0
| 108
| 100
| 120
| 14
| 36.3
| 0.29
| 1,423
| 0.96
| 24.5
| 2.3
| 23.1
| 40.2
| 8.3
| 17.8
| 33.3
| 24.4
| 4.9
| 10.6
|
imp_561630
|
p16542775
| 15
|
Very High
|
[
"files/p16542775/p165427751765/s28883274/",
"files/p16542775/p165427754904/s28342286/",
"files/p16542775/p165427751355/s34476064/"
] |
[
"p1654/p16542775/s42752652",
"p1654/p16542775/s43189255",
"p1654/p16542775/s45355397",
"p1654/p16542775/s45553799",
"p1654/p16542775/s46581052",
"p1654/p16542775/s47181146",
"p1654/p16542775/s49068156"
] |
Patient p16542775 is a 82-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 82
|
M
| 0
| 1
| 0
| 0
| 1
| 58.1
| 190.7
| 0
| 151
| 87
| 86
| 20
| 38.9
| 4.56
| 222
| 2.93
| 21.6
| 2.5
| 5.3
| 10.6
| 8
| 12.4
| 47.4
| 39.2
| 4.6
| 10.4
|
imp_993631
|
p16542795
| 12
|
Very High
|
[
"files/p16542795/p165427955118/s22605827/",
"files/p16542795/p165427952069/s10017850/",
"files/p16542795/p165427954094/s66811657/"
] |
[
"p1654/p16542795/s40322182",
"p1654/p16542795/s42841546",
"p1654/p16542795/s47765760",
"p1654/p16542795/s48431755",
"p1654/p16542795/s49815534",
"p1654/p16542795/s49903611"
] |
Patient p16542795 is a 75-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 75
|
M
| 0
| 1
| 0
| 0
| 0
| 11.5
| 209.5
| 0
| 145
| 100
| 71
| 25
| 36.5
| 3.9
| 1,202
| 1.09
| 30.7
| 2.7
| 13.2
| 37.3
| 14.8
| 18.6
| 36.1
| 7.4
| 17.2
| 4.6
|
imp_583124
|
p16542834
| 18
|
Very High
|
[
"files/p16542834/p165428349458/s33513225/"
] |
[
"p1654/p16542834/s43443592",
"p1654/p16542834/s43476757",
"p1654/p16542834/s44997812",
"p1654/p16542834/s45251002"
] |
Patient p16542834 is a 66-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 66
|
F
| 1
| 1
| 0
| 1
| 1
| 43.8
| 78.2
| 0
| 109
| 110
| 71
| 20
| 37.9
| 1.55
| 1,720
| 1.72
| 49.5
| 2.6
| 4.5
| 40.1
| 10.7
| 20
| 37.7
| 4.4
| 20
| 2.6
|
imp_701195
|
p16542863
| 13.5
|
Very High
|
[
"files/p16542863/p165428633265/s49370768/",
"files/p16542863/p165428635864/s38510236/"
] |
[
"p1654/p16542863/s40932917"
] |
Patient p16542863 is a 79-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 79
|
F
| 0
| 0
| 1
| 0
| 0
| 56.6
| 106.5
| 1
| 150
| 72
| 59
| 12
| 37.2
| 0.4
| 1,556
| 0.75
| 54.3
| 2
| 15.8
| 27.5
| 14.2
| 4.4
| 46.5
| 34.2
| 5.2
| 4.3
|
imp_648159
|
p16543076
| 17
|
Very High
|
[
"files/p16543076/p165430762156/s98562616/",
"files/p16543076/p165430769606/s91154743/"
] |
[
"p1654/p16543076/s40951910",
"p1654/p16543076/s42449035",
"p1654/p16543076/s46986939",
"p1654/p16543076/s47564108",
"p1654/p16543076/s48239307",
"p1654/p16543076/s48369654"
] |
Patient p16543076 is a 60-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 60
|
F
| 0
| 1
| 0
| 1
| 1
| 38.1
| 350.9
| 1
| 157
| 83
| 56
| 18
| 37.7
| 4.35
| 1,933
| 1.23
| 58.4
| 1.9
| 3.4
| 26.7
| 16.8
| 14.4
| 56.2
| 26.1
| 19.5
| 8.2
|
imp_139086
|
p16543302
| 19.5
|
Very High
|
[
"files/p16543302/p165433021148/s91618861/"
] |
[
"p1654/p16543302/s44012166"
] |
Patient p16543302 is a 66-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 66
|
M
| 1
| 0
| 0
| 1
| 0
| 54.8
| 475.2
| 0
| 179
| 103
| 74
| 14
| 38.1
| 4.25
| 2,954
| 2.08
| 54.2
| 2
| 3
| 20.7
| 14.9
| 19.8
| 43.3
| 3.4
| 12.1
| 13.2
|
imp_518059
|
p16543411
| 19.5
|
Very High
|
[
"files/p16543411/p165434116429/s74863590/",
"files/p16543411/p165434112377/s53094912/",
"files/p16543411/p165434115402/s54057731/"
] |
[
"p1654/p16543411/s48931412",
"p1654/p16543411/s49622353"
] |
Patient p16543411 is a 73-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 73
|
M
| 1
| 1
| 1
| 1
| 0
| 19
| 352.1
| 0
| 147
| 89
| 104
| 25
| 37.1
| 2.46
| 3,363
| 1.31
| 25.3
| 2.8
| 19.2
| 15.2
| 13.8
| 22.4
| 51.5
| 36.9
| 18.7
| 1.1
|
imp_952660
|
p16543672
| 13.5
|
Very High
|
[
"files/p16543672/p165436723078/s55915416/",
"files/p16543672/p165436721943/s62211236/",
"files/p16543672/p165436726301/s69400145/"
] |
[
"p1654/p16543672/s40786851"
] |
Patient p16543672 is a 78-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 78
|
M
| 0
| 0
| 1
| 1
| 0
| 1.3
| 393.9
| 0
| 119
| 74
| 89
| 20
| 37.8
| 3.08
| 3,143
| 1.52
| 53
| 2.2
| 19.5
| 23.3
| 12.7
| 12.8
| 49.1
| 21.2
| 6.4
| 9.9
|
imp_944334
|
p16543694
| 13
|
Very High
|
[
"files/p16543694/p165436942137/s86288552/",
"files/p16543694/p165436944623/s37077018/"
] |
[
"p1654/p16543694/s46039037"
] |
Patient p16543694 is a 45-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 45
|
M
| 0
| 0
| 0
| 1
| 1
| 58.2
| 299.7
| 1
| 128
| 66
| 99
| 24
| 37.2
| 4.82
| 1,094
| 1.19
| 64.3
| 2
| 4.4
| 30
| 4.9
| 28.4
| 51.6
| 30.5
| 23.9
| 2.7
|
imp_758629
|
p16543731
| 11
|
High
|
[
"files/p16543731/p165437311061/s13953310/"
] |
[
"p1654/p16543731/s45077536"
] |
Patient p16543731 is a 30-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 30
|
M
| 0
| 1
| 0
| 0
| 1
| 18.4
| 548.6
| 0
| 100
| 83
| 68
| 12
| 38.5
| 0.33
| 1,670
| 0.77
| 42.1
| 2.4
| 21.9
| 36.5
| 8.1
| 15.9
| 46.4
| 8.3
| 11.8
| 12.7
|
imp_880545
|
p16543832
| 15
|
Very High
|
[
"files/p16543832/p165438325658/s62794229/",
"files/p16543832/p165438324497/s42998085/",
"files/p16543832/p165438324019/s30766900/"
] |
[
"p1654/p16543832/s41733639",
"p1654/p16543832/s44687053",
"p1654/p16543832/s46303807",
"p1654/p16543832/s49201269"
] |
Patient p16543832 is a 65-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 65
|
F
| 0
| 0
| 1
| 0
| 1
| 0.4
| 412.2
| 1
| 155
| 81
| 105
| 25
| 38.7
| 1.53
| 2,745
| 1.33
| 19.7
| 2.4
| 19.9
| 23.1
| 18.3
| 8.2
| 31.3
| 28.5
| 15.7
| 7.7
|
imp_915404
|
p16543879
| 14
|
Very High
|
[
"files/p16543879/p165438793466/s93942023/",
"files/p16543879/p165438799073/s27217582/"
] |
[
"p1654/p16543879/s42977439",
"p1654/p16543879/s46939834"
] |
Patient p16543879 is a 87-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 87
|
M
| 0
| 1
| 0
| 1
| 0
| 55.4
| 199.5
| 0
| 138
| 62
| 76
| 25
| 38.7
| 4.12
| 2,300
| 1.28
| 20.3
| 2.9
| 17.9
| 27.2
| 5.3
| 17.8
| 35.3
| 3.4
| 16.9
| 11.3
|
imp_552772
|
p16543901
| 17
|
Very High
|
[
"files/p16543901/p165439018649/s72738656/",
"files/p16543901/p165439014338/s39305626/"
] |
[
"p1654/p16543901/s46440151",
"p1654/p16543901/s47423629"
] |
Patient p16543901 is a 52-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 52
|
F
| 1
| 1
| 0
| 0
| 1
| 41.2
| 180.3
| 0
| 98
| 98
| 111
| 15
| 37.2
| 0.78
| 3,187
| 0.95
| 67.2
| 2.9
| 5.6
| 43.5
| 9.2
| 33.9
| 21.4
| 23.5
| 24.7
| 1.6
|
imp_801569
|
p16543938
| 15
|
Very High
|
[
"files/p16543938/p165439389294/s65588616/"
] |
[
"p1654/p16543938/s40001187",
"p1654/p16543938/s40185707",
"p1654/p16543938/s40210235",
"p1654/p16543938/s40300565",
"p1654/p16543938/s40562600",
"p1654/p16543938/s42166707",
"p1654/p16543938/s42207483",
"p1654/p16543938/s42369878",
"p1654/p16543938/s42635337",
"p1654/p16543938/s42717352",
"p1654/p16543938/s42745690",
"p1654/p16543938/s42820939",
"p1654/p16543938/s42826855",
"p1654/p16543938/s43374640",
"p1654/p16543938/s43823953",
"p1654/p16543938/s44087867",
"p1654/p16543938/s44636184",
"p1654/p16543938/s44773886",
"p1654/p16543938/s45077733",
"p1654/p16543938/s45100221",
"p1654/p16543938/s46507009",
"p1654/p16543938/s46536531",
"p1654/p16543938/s46542708",
"p1654/p16543938/s46586974",
"p1654/p16543938/s46828345",
"p1654/p16543938/s46933371",
"p1654/p16543938/s47597746",
"p1654/p16543938/s48258767",
"p1654/p16543938/s48753025",
"p1654/p16543938/s48906526",
"p1654/p16543938/s49565085",
"p1654/p16543938/s49773553",
"p1654/p16543938/s49967430"
] |
Patient p16543938 is a 33-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 33
|
F
| 0
| 0
| 0
| 1
| 0
| 56.5
| 570.6
| 0
| 156
| 60
| 75
| 21
| 37.5
| 4.63
| 2,717
| 2.34
| 25.5
| 2.8
| 14.9
| 31.5
| 15.2
| 34.4
| 25.9
| 3.4
| 24.6
| 12.6
|
imp_126886
|
p16544053
| 19
|
Very High
|
[
"files/p16544053/p165440537527/s14532520/",
"files/p16544053/p165440535894/s63929902/",
"files/p16544053/p165440531463/s74175195/"
] |
[
"p1654/p16544053/s40029949",
"p1654/p16544053/s41034743",
"p1654/p16544053/s44659391",
"p1654/p16544053/s46239236",
"p1654/p16544053/s46514282",
"p1654/p16544053/s47048734"
] |
Patient p16544053 is a 77-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 77
|
M
| 1
| 0
| 1
| 1
| 0
| 19.1
| 524.8
| 0
| 140
| 80
| 68
| 22
| 37.1
| 1.5
| 3,602
| 1.96
| 62.6
| 2.3
| 18.7
| 25.2
| 4.7
| 16.3
| 12
| 35.1
| 2.2
| 14
|
imp_326533
|
p16544105
| 16.5
|
Very High
|
[
"files/p16544105/p165441054396/s10462918/",
"files/p16544105/p165441056922/s84962170/"
] |
[
"p1654/p16544105/s42211156"
] |
Patient p16544105 is a 30-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 30
|
M
| 1
| 0
| 1
| 1
| 0
| 50.8
| 52
| 1
| 142
| 92
| 60
| 22
| 37.5
| 0.57
| 4,146
| 1.69
| 40.6
| 2.8
| 16
| 11.5
| 3.5
| 25.4
| 23.5
| 20.9
| 21.8
| 10.8
|
imp_694469
|
p16544114
| 15.5
|
Very High
|
[
"files/p16544114/p165441147200/s41949215/"
] |
[
"p1654/p16544114/s40456403",
"p1654/p16544114/s42346376",
"p1654/p16544114/s43085814",
"p1654/p16544114/s47108941",
"p1654/p16544114/s48907908",
"p1654/p16544114/s49099077",
"p1654/p16544114/s49460760"
] |
Patient p16544114 is a 53-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 53
|
F
| 1
| 1
| 0
| 0
| 1
| 6.9
| 242
| 0
| 111
| 64
| 91
| 22
| 36.2
| 4
| 4,553
| 2.37
| 38.4
| 2.2
| 7.5
| 25.9
| 18
| 33.2
| 44.3
| 18.8
| 20.4
| 3.2
|
imp_289517
|
p16544163
| 23
|
Very High
|
[
"files/p16544163/p165441636131/s54970734/"
] |
[
"p1654/p16544163/s44641304",
"p1654/p16544163/s45007127",
"p1654/p16544163/s48977330"
] |
Patient p16544163 is a 77-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 77
|
F
| 1
| 1
| 1
| 1
| 1
| 4.7
| 453.2
| 1
| 178
| 74
| 103
| 23
| 38.6
| 1.37
| 1,629
| 1.13
| 20.8
| 2.2
| 22
| 9.7
| 17.1
| 27.4
| 23.3
| 9.9
| 10.7
| 14.5
|
imp_125317
|
p16544239
| 17
|
Very High
|
[
"files/p16544239/p165442399248/s93739102/"
] |
[
"p1654/p16544239/s40746818",
"p1654/p16544239/s42829350",
"p1654/p16544239/s43460362",
"p1654/p16544239/s45094442",
"p1654/p16544239/s45680702",
"p1654/p16544239/s45701221",
"p1654/p16544239/s46685819",
"p1654/p16544239/s48094158",
"p1654/p16544239/s49616628",
"p1654/p16544239/s49953929"
] |
Patient p16544239 is a 66-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 66
|
F
| 1
| 1
| 0
| 1
| 0
| 4
| 421.7
| 1
| 124
| 88
| 83
| 12
| 39
| 1.69
| 2,859
| 1.09
| 26.8
| 2.3
| 23.1
| 6.7
| 11.5
| 15.2
| 7.4
| 31.9
| 24.1
| 1.2
|
imp_761149
|
p16544240
| 17
|
Very High
|
[
"files/p16544240/p165442405713/s28155906/",
"files/p16544240/p165442401615/s21383588/"
] |
[
"p1654/p16544240/s40139316",
"p1654/p16544240/s40572650",
"p1654/p16544240/s40584318",
"p1654/p16544240/s40742091",
"p1654/p16544240/s41343381",
"p1654/p16544240/s41428709",
"p1654/p16544240/s41566722",
"p1654/p16544240/s41632280",
"p1654/p16544240/s42295411",
"p1654/p16544240/s42769397",
"p1654/p16544240/s43110549",
"p1654/p16544240/s43238612",
"p1654/p16544240/s43445595",
"p1654/p16544240/s43807551",
"p1654/p16544240/s43882754",
"p1654/p16544240/s44114913",
"p1654/p16544240/s45029206",
"p1654/p16544240/s46048787",
"p1654/p16544240/s46105305",
"p1654/p16544240/s46267745",
"p1654/p16544240/s47238282",
"p1654/p16544240/s47373504",
"p1654/p16544240/s47478607",
"p1654/p16544240/s47586539",
"p1654/p16544240/s47631831",
"p1654/p16544240/s47660908",
"p1654/p16544240/s48082687",
"p1654/p16544240/s48575010",
"p1654/p16544240/s49031547",
"p1654/p16544240/s49643328",
"p1654/p16544240/s49715807",
"p1654/p16544240/s49849188"
] |
Patient p16544240 is a 89-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 89
|
F
| 0
| 0
| 1
| 0
| 0
| 58.5
| 177.5
| 1
| 156
| 105
| 66
| 19
| 37.4
| 2.91
| 1,773
| 1.76
| 12.1
| 2.6
| 2.4
| 39.1
| 10.4
| 27.4
| 46
| 40
| 17.6
| 2
|
imp_444941
|
p16544249
| 15
|
Very High
|
[
"files/p16544249/p165442495874/s73473812/",
"files/p16544249/p165442493167/s17200210/",
"files/p16544249/p165442495427/s76579910/"
] |
[
"p1654/p16544249/s46714828",
"p1654/p16544249/s48789877"
] |
Patient p16544249 is a 59-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 59
|
M
| 0
| 0
| 0
| 1
| 1
| 4.1
| 523
| 0
| 169
| 72
| 111
| 22
| 37.5
| 4.07
| 4,602
| 1.53
| 59.9
| 2.1
| 14.3
| 13.5
| 18.2
| 5.4
| 13.9
| 36.7
| 8.2
| 14.4
|
imp_203603
|
p16544339
| 17
|
Very High
|
[
"files/p16544339/p165443398116/s96973592/"
] |
[
"p1654/p16544339/s41577450",
"p1654/p16544339/s43441223",
"p1654/p16544339/s43447807"
] |
Patient p16544339 is a 28-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 28
|
F
| 0
| 1
| 1
| 1
| 0
| 25.1
| 583.4
| 1
| 108
| 95
| 51
| 15
| 37.1
| 3.3
| 4,879
| 1.92
| 38.7
| 1.9
| 2.4
| 33.8
| 13
| 20.2
| 6.9
| 16.6
| 10.4
| 11.7
|
imp_406474
|
p16544353
| 17
|
Very High
|
[
"files/p16544353/p165443539295/s59234268/",
"files/p16544353/p165443538012/s32414961/"
] |
[
"p1654/p16544353/s40157462",
"p1654/p16544353/s40749522",
"p1654/p16544353/s40760215",
"p1654/p16544353/s40801514",
"p1654/p16544353/s41245785",
"p1654/p16544353/s41462094",
"p1654/p16544353/s41519782",
"p1654/p16544353/s41691044",
"p1654/p16544353/s41794606",
"p1654/p16544353/s41889129",
"p1654/p16544353/s43236987",
"p1654/p16544353/s43557806",
"p1654/p16544353/s44461818",
"p1654/p16544353/s44854311",
"p1654/p16544353/s45288401",
"p1654/p16544353/s45591323",
"p1654/p16544353/s45944155",
"p1654/p16544353/s45970388",
"p1654/p16544353/s46197057",
"p1654/p16544353/s46535869",
"p1654/p16544353/s46584140",
"p1654/p16544353/s46730379",
"p1654/p16544353/s46778008",
"p1654/p16544353/s46865880",
"p1654/p16544353/s47460386",
"p1654/p16544353/s47520356",
"p1654/p16544353/s48311430",
"p1654/p16544353/s48447704",
"p1654/p16544353/s48575471",
"p1654/p16544353/s48651497",
"p1654/p16544353/s49086261",
"p1654/p16544353/s49088822",
"p1654/p16544353/s49098523",
"p1654/p16544353/s49511876",
"p1654/p16544353/s49949360",
"p1654/p16544353/s49958299"
] |
Patient p16544353 is a 94-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 94
|
M
| 1
| 1
| 0
| 1
| 0
| 21
| 9.4
| 0
| 109
| 98
| 104
| 20
| 36.4
| 1.47
| 742
| 2.69
| 34.8
| 2.8
| 3.6
| 44.1
| 7.1
| 9.5
| 36.7
| 13.7
| 21.8
| 7
|
imp_532164
|
p16544403
| 17
|
Very High
|
[
"files/p16544403/p165444033256/s66404731/",
"files/p16544403/p165444031039/s59828367/"
] |
[
"p1654/p16544403/s40550304",
"p1654/p16544403/s41364430",
"p1654/p16544403/s41596468",
"p1654/p16544403/s42087344",
"p1654/p16544403/s43075793",
"p1654/p16544403/s43617752",
"p1654/p16544403/s43917057",
"p1654/p16544403/s45078710",
"p1654/p16544403/s45996657",
"p1654/p16544403/s46825950",
"p1654/p16544403/s47031411",
"p1654/p16544403/s47140736",
"p1654/p16544403/s47653058",
"p1654/p16544403/s47898074",
"p1654/p16544403/s48897946",
"p1654/p16544403/s49631664"
] |
Patient p16544403 is a 94-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 94
|
M
| 1
| 1
| 0
| 1
| 0
| 4.7
| 173.5
| 0
| 141
| 96
| 75
| 20
| 38.1
| 4.76
| 3,687
| 2.97
| 18.1
| 2.1
| 19.9
| 22.9
| 5
| 28.4
| 48.8
| 33.4
| 14.9
| 9.7
|
imp_940848
|
p16544417
| 14
|
Very High
|
[
"files/p16544417/p165444171225/s31461553/",
"files/p16544417/p165444175015/s15370027/"
] |
[
"p1654/p16544417/s44710849",
"p1654/p16544417/s44935353",
"p1654/p16544417/s48695350"
] |
Patient p16544417 is a 18-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 18
|
M
| 1
| 1
| 1
| 1
| 1
| 14.3
| 312.1
| 1
| 124
| 85
| 56
| 19
| 37.7
| 0.86
| 21
| 1.34
| 33.3
| 2.9
| 21.3
| 19.2
| 17.6
| 17.4
| 34.1
| 2.2
| 10.3
| 10.5
|
imp_129752
|
p16544497
| 17
|
Very High
|
[
"files/p16544497/p165444974127/s64336432/",
"files/p16544497/p165444976846/s78230475/",
"files/p16544497/p165444977611/s95133330/"
] |
[
"p1654/p16544497/s40634893"
] |
Patient p16544497 is a 77-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 77
|
F
| 0
| 0
| 0
| 0
| 1
| 39.1
| 554.7
| 0
| 161
| 70
| 55
| 16
| 36.6
| 4.15
| 2,572
| 2.29
| 62.7
| 2
| 12.5
| 38
| 19.5
| 17.2
| 46.8
| 21.5
| 12.2
| 9.2
|
imp_864472
|
p16544722
| 16.5
|
Very High
|
[
"files/p16544722/p165447222162/s65247109/",
"files/p16544722/p165447228337/s47946640/"
] |
[
"p1654/p16544722/s40242480",
"p1654/p16544722/s40243878",
"p1654/p16544722/s40677297",
"p1654/p16544722/s40815351",
"p1654/p16544722/s40897403",
"p1654/p16544722/s41125418",
"p1654/p16544722/s41281937",
"p1654/p16544722/s41456284",
"p1654/p16544722/s41574302",
"p1654/p16544722/s42359315",
"p1654/p16544722/s42460565",
"p1654/p16544722/s42476535",
"p1654/p16544722/s42499533",
"p1654/p16544722/s42547173",
"p1654/p16544722/s42573850",
"p1654/p16544722/s42907685",
"p1654/p16544722/s42952495",
"p1654/p16544722/s43062518",
"p1654/p16544722/s43244297",
"p1654/p16544722/s43760076",
"p1654/p16544722/s43869366",
"p1654/p16544722/s43875438",
"p1654/p16544722/s43978689",
"p1654/p16544722/s44177961",
"p1654/p16544722/s44896549",
"p1654/p16544722/s45018734",
"p1654/p16544722/s45071078",
"p1654/p16544722/s45113113",
"p1654/p16544722/s45246639",
"p1654/p16544722/s45682111",
"p1654/p16544722/s45700702",
"p1654/p16544722/s45944998",
"p1654/p16544722/s45957090",
"p1654/p16544722/s46270254",
"p1654/p16544722/s46627765",
"p1654/p16544722/s46832654",
"p1654/p16544722/s47148457",
"p1654/p16544722/s47252865",
"p1654/p16544722/s47355438",
"p1654/p16544722/s47485264",
"p1654/p16544722/s47888787",
"p1654/p16544722/s47990746",
"p1654/p16544722/s48067565",
"p1654/p16544722/s49180308",
"p1654/p16544722/s49294469",
"p1654/p16544722/s49525605",
"p1654/p16544722/s49550885",
"p1654/p16544722/s49669403",
"p1654/p16544722/s49803352"
] |
Patient p16544722 is a 68-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 68
|
F
| 1
| 1
| 0
| 0
| 0
| 5.7
| 588.3
| 0
| 152
| 60
| 89
| 22
| 36.9
| 1.98
| 2,843
| 0.69
| 55.2
| 2.4
| 22.5
| 24.6
| 9.3
| 29.8
| 42.1
| 25.7
| 15.1
| 12.9
|
imp_578804
|
p16544724
| 15.5
|
Very High
|
[
"files/p16544724/p165447248957/s52286809/",
"files/p16544724/p165447244422/s96662893/"
] |
[
"p1654/p16544724/s48184819"
] |
Patient p16544724 is a 64-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 64
|
M
| 0
| 1
| 0
| 1
| 1
| 59.4
| 361.2
| 0
| 130
| 71
| 91
| 22
| 38.1
| 1.09
| 3,243
| 0.98
| 58.1
| 2.7
| 21.9
| 8.2
| 18.1
| 27.2
| 20.8
| 31.6
| 19.1
| 4.6
|
imp_990691
|
p16544747
| 11.5
|
High
|
[
"files/p16544747/p165447474564/s80158105/"
] |
[
"p1654/p16544747/s40853831",
"p1654/p16544747/s41724191",
"p1654/p16544747/s42220712",
"p1654/p16544747/s44094930",
"p1654/p16544747/s45383423",
"p1654/p16544747/s46059926",
"p1654/p16544747/s46880965",
"p1654/p16544747/s47667517",
"p1654/p16544747/s48264481",
"p1654/p16544747/s48629371",
"p1654/p16544747/s49480490"
] |
Patient p16544747 is a 33-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 33
|
M
| 0
| 0
| 1
| 0
| 0
| 30.6
| 358.4
| 1
| 114
| 71
| 116
| 18
| 37
| 4.86
| 727
| 0.66
| 49.4
| 2.5
| 5.6
| 20.8
| 18.6
| 10.1
| 45
| 3.5
| 21.7
| 12.5
|
imp_365828
|
p16544814
| 17.5
|
Very High
|
[
"files/p16544814/p165448148936/s86602473/",
"files/p16544814/p165448149874/s87083309/",
"files/p16544814/p165448142267/s47285195/"
] |
[
"p1654/p16544814/s44812357"
] |
Patient p16544814 is a 65-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 65
|
M
| 0
| 0
| 1
| 1
| 0
| 3.5
| 527.6
| 1
| 104
| 108
| 109
| 18
| 37.3
| 4
| 3,105
| 2.05
| 54.2
| 2.2
| 21.1
| 25.4
| 13.4
| 31.7
| 59.8
| 7.3
| 21.7
| 13.4
|
imp_476007
|
p16544816
| 14
|
Very High
|
[
"files/p16544816/p165448169291/s90361803/",
"files/p16544816/p165448161563/s67344434/"
] |
[
"p1654/p16544816/s44416579"
] |
Patient p16544816 is a 36-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 36
|
M
| 0
| 1
| 0
| 1
| 1
| 67.8
| 293.7
| 0
| 144
| 101
| 70
| 22
| 37.3
| 3.04
| 2,363
| 0.78
| 39.1
| 2
| 14.9
| 10.7
| 13.9
| 21.8
| 5
| 16.1
| 8.2
| 3.7
|
imp_958121
|
p16544862
| 8.5
|
High
|
[
"files/p16544862/p165448626160/s93244633/",
"files/p16544862/p165448621232/s52088357/",
"files/p16544862/p165448624400/s47862236/"
] |
[
"p1654/p16544862/s40264172",
"p1654/p16544862/s48816251"
] |
Patient p16544862 is a 21-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 21
|
F
| 0
| 0
| 0
| 0
| 0
| 9
| 296.6
| 0
| 113
| 81
| 58
| 23
| 37
| 1.48
| 1,025
| 2.86
| 53.9
| 2
| 2.5
| 42.2
| 18
| 27.3
| 30.4
| 9.8
| 3.5
| 5.4
|
imp_816189
|
p16544911
| 17
|
Very High
|
[
"files/p16544911/p165449118151/s65961535/"
] |
[
"p1654/p16544911/s42259458",
"p1654/p16544911/s42307124",
"p1654/p16544911/s44424024",
"p1654/p16544911/s44621753",
"p1654/p16544911/s47203798",
"p1654/p16544911/s47625412"
] |
Patient p16544911 is a 45-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 45
|
M
| 1
| 0
| 1
| 1
| 1
| 49.9
| 541.3
| 0
| 145
| 78
| 110
| 25
| 38.6
| 1.7
| 370
| 1.85
| 57.1
| 2.3
| 22.4
| 14.2
| 2.7
| 26.9
| 23.6
| 33.5
| 11
| 1.9
|
imp_460762
|
p16544940
| 19.5
|
Very High
|
[
"files/p16544940/p165449403089/s39055218/",
"files/p16544940/p165449404644/s27688295/"
] |
[
"p1654/p16544940/s41730412",
"p1654/p16544940/s41955760",
"p1654/p16544940/s42171320",
"p1654/p16544940/s42828219",
"p1654/p16544940/s43255935",
"p1654/p16544940/s43860776",
"p1654/p16544940/s43933624",
"p1654/p16544940/s44100805",
"p1654/p16544940/s44405160",
"p1654/p16544940/s44582461",
"p1654/p16544940/s45235781",
"p1654/p16544940/s45622240",
"p1654/p16544940/s46652722",
"p1654/p16544940/s47053831",
"p1654/p16544940/s47583784",
"p1654/p16544940/s48057365",
"p1654/p16544940/s49090939",
"p1654/p16544940/s49105957",
"p1654/p16544940/s49643435",
"p1654/p16544940/s49670763",
"p1654/p16544940/s49762014",
"p1654/p16544940/s49769730"
] |
Patient p16544940 is a 60-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 60
|
F
| 1
| 1
| 0
| 0
| 1
| 50.8
| 485.9
| 0
| 122
| 78
| 57
| 12
| 36.6
| 4.57
| 2,093
| 1.86
| 18.8
| 2.4
| 19.5
| 28.8
| 19.7
| 18
| 39.8
| 22.3
| 24.4
| 2.6
|
imp_469495
|
p16544972
| 12
|
Very High
|
[
"files/p16544972/p165449727242/s44528840/",
"files/p16544972/p165449723142/s23613606/",
"files/p16544972/p165449723571/s23535093/"
] |
[
"p1654/p16544972/s41316265",
"p1654/p16544972/s43900311",
"p1654/p16544972/s45488877"
] |
Patient p16544972 is a 22-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 22
|
F
| 0
| 0
| 0
| 0
| 0
| 29.8
| 373.1
| 0
| 152
| 62
| 101
| 14
| 37.8
| 3.15
| 1,616
| 1.56
| 19.7
| 2.5
| 14.1
| 32.4
| 8.4
| 28.8
| 17.3
| 17.4
| 5.1
| 12.1
|
imp_360781
|
p16545105
| 17
|
Very High
|
[
"files/p16545105/p165451059743/s83558381/",
"files/p16545105/p165451052222/s97364536/",
"files/p16545105/p165451052709/s98655223/"
] |
[
"p1654/p16545105/s41024079",
"p1654/p16545105/s42151688",
"p1654/p16545105/s45543062",
"p1654/p16545105/s45550552",
"p1654/p16545105/s45763357",
"p1654/p16545105/s45788967"
] |
Patient p16545105 is a 82-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 82
|
F
| 1
| 1
| 1
| 1
| 0
| 7.6
| 95.5
| 0
| 109
| 91
| 89
| 17
| 37.2
| 0.17
| 3,056
| 2.18
| 67.7
| 2.1
| 23.7
| 25.6
| 7
| 11.2
| 36
| 34.9
| 9.8
| 9.9
|
imp_390070
|
p16545163
| 21
|
Very High
|
[
"files/p16545163/p165451635723/s92667094/",
"files/p16545163/p165451636561/s85482020/"
] |
[
"p1654/p16545163/s47735652"
] |
Patient p16545163 is a 46-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 46
|
F
| 1
| 1
| 1
| 1
| 1
| 25.8
| 574.4
| 1
| 163
| 80
| 85
| 21
| 38.1
| 3.85
| 4,406
| 0.5
| 20.8
| 2.2
| 7.3
| 35
| 16.8
| 18.3
| 5
| 23.3
| 10.3
| 15
|
imp_567672
|
p16545167
| 20.5
|
Very High
|
[
"files/p16545167/p165451671266/s43752783/"
] |
[
"p1654/p16545167/s41771294"
] |
Patient p16545167 is a 68-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 68
|
F
| 1
| 0
| 0
| 1
| 1
| 15.2
| 530.4
| 1
| 106
| 94
| 61
| 21
| 38.2
| 2.73
| 4,939
| 2.47
| 25.8
| 2.4
| 5
| 42.2
| 3.4
| 25.8
| 37.8
| 35.7
| 1.9
| 9.5
|
imp_921779
|
p16545275
| 16.5
|
Very High
|
[
"files/p16545275/p165452753989/s19829329/"
] |
[
"p1654/p16545275/s49476542"
] |
Patient p16545275 is a 85-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 85
|
M
| 0
| 1
| 0
| 0
| 0
| 50.2
| 344.7
| 0
| 127
| 91
| 54
| 15
| 38.6
| 1.46
| 1,448
| 2.63
| 23.1
| 2
| 17.9
| 18.5
| 8.1
| 24.7
| 24.7
| 7.9
| 12.8
| 1.1
|
imp_150121
|
p16545345
| 20.5
|
Very High
|
[
"files/p16545345/p165453458158/s70455694/",
"files/p16545345/p165453453252/s31924339/",
"files/p16545345/p165453459700/s35918591/"
] |
[
"p1654/p16545345/s44306063",
"p1654/p16545345/s47739986"
] |
Patient p16545345 is a 70-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 70
|
F
| 1
| 1
| 0
| 0
| 1
| 19.9
| 341.5
| 1
| 148
| 106
| 112
| 20
| 38.7
| 4.94
| 214
| 2.15
| 39.8
| 2.3
| 9.8
| 44.2
| 5.7
| 32.7
| 50.4
| 38
| 23
| 9.8
|
imp_440275
|
p16545399
| 10
|
High
|
[
"files/p16545399/p165453999154/s50827124/",
"files/p16545399/p165453993828/s50288298/",
"files/p16545399/p165453993647/s95493329/"
] |
[
"p1654/p16545399/s43835049"
] |
Patient p16545399 is a 21-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 21
|
F
| 0
| 0
| 0
| 0
| 1
| 27.7
| 448.3
| 0
| 95
| 68
| 65
| 18
| 37.5
| 1.39
| 4,854
| 0.89
| 34.1
| 2.6
| 17.8
| 6.3
| 11.1
| 18.3
| 32.2
| 27.8
| 23.1
| 10.7
|
imp_580462
|
p16545417
| 19.5
|
Very High
|
[
"files/p16545417/p165454178554/s63377272/",
"files/p16545417/p165454179055/s77647844/"
] |
[
"p1654/p16545417/s42998139",
"p1654/p16545417/s43886271",
"p1654/p16545417/s44704847",
"p1654/p16545417/s45335735",
"p1654/p16545417/s45793436",
"p1654/p16545417/s48560885",
"p1654/p16545417/s49372333"
] |
Patient p16545417 is a 73-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 73
|
F
| 0
| 0
| 0
| 1
| 0
| 54.7
| 499.4
| 1
| 134
| 94
| 113
| 23
| 37
| 2.92
| 2,051
| 1.64
| 65.7
| 2.9
| 13
| 21.5
| 9.7
| 13.3
| 33.5
| 29.1
| 17.2
| 0.8
|
imp_833064
|
p16545442
| 23
|
Very High
|
[
"files/p16545442/p165454429211/s78906283/"
] |
[
"p1654/p16545442/s44965046",
"p1654/p16545442/s46758026"
] |
Patient p16545442 is a 78-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 78
|
F
| 1
| 1
| 0
| 1
| 1
| 49.7
| 512.9
| 0
| 142
| 64
| 113
| 21
| 37.5
| 0.75
| 2,254
| 2.96
| 40
| 2.3
| 18.8
| 43.7
| 10
| 27.3
| 21.8
| 10.4
| 2.9
| 14.8
|
imp_765643
|
p16545530
| 17
|
Very High
|
[
"files/p16545530/p165455303109/s28970845/",
"files/p16545530/p165455308376/s37518599/",
"files/p16545530/p165455309946/s80579679/"
] |
[
"p1654/p16545530/s41205018",
"p1654/p16545530/s41592623",
"p1654/p16545530/s42453093",
"p1654/p16545530/s43080684",
"p1654/p16545530/s45056945",
"p1654/p16545530/s48036324",
"p1654/p16545530/s48112131",
"p1654/p16545530/s49873993"
] |
Patient p16545530 is a 85-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 85
|
M
| 1
| 0
| 0
| 0
| 0
| 4.3
| 218.8
| 1
| 160
| 75
| 98
| 18
| 36.5
| 3.56
| 3,084
| 2.67
| 54.8
| 2.7
| 13.4
| 18.2
| 17.9
| 24.6
| 39.5
| 18.1
| 13.3
| 4.7
|
imp_375957
|
p16545709
| 14.5
|
Very High
|
[
"files/p16545709/p165457091947/s74837748/",
"files/p16545709/p165457099956/s54268735/",
"files/p16545709/p165457092104/s48939663/"
] |
[
"p1654/p16545709/s46048527"
] |
Patient p16545709 is a 52-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 52
|
M
| 0
| 0
| 0
| 1
| 1
| 60.6
| 36.6
| 0
| 156
| 67
| 105
| 24
| 37
| 2.53
| 3,887
| 2.84
| 51
| 2.5
| 6.6
| 31.3
| 13.6
| 32.6
| 40.5
| 2.4
| 3.2
| 9.7
|
imp_905947
|
p16545883
| 13
|
Very High
|
[
"files/p16545883/p165458831810/s80082665/",
"files/p16545883/p165458832262/s61595935/"
] |
[
"p1654/p16545883/s43455933",
"p1654/p16545883/s44967981",
"p1654/p16545883/s46901096"
] |
Patient p16545883 is a 57-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 57
|
F
| 0
| 0
| 1
| 1
| 0
| 50.4
| 77
| 1
| 132
| 75
| 55
| 13
| 36.7
| 0.27
| 2,252
| 1.8
| 31
| 2.3
| 15.7
| 41.7
| 10.5
| 12.8
| 48.2
| 7.2
| 15.1
| 11.4
|
imp_932192
|
p16545947
| 17.5
|
Very High
|
[
"files/p16545947/p165459475184/s36833950/",
"files/p16545947/p165459477063/s87246939/",
"files/p16545947/p165459476012/s63796351/"
] |
[
"p1654/p16545947/s41409605",
"p1654/p16545947/s43070959",
"p1654/p16545947/s43697113",
"p1654/p16545947/s43745650",
"p1654/p16545947/s43904326",
"p1654/p16545947/s45809494",
"p1654/p16545947/s45810522",
"p1654/p16545947/s47252807",
"p1654/p16545947/s48312920",
"p1654/p16545947/s48606494",
"p1654/p16545947/s48932017",
"p1654/p16545947/s49099065"
] |
Patient p16545947 is a 93-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 93
|
M
| 0
| 1
| 0
| 0
| 1
| 54.7
| 454.8
| 1
| 115
| 63
| 118
| 16
| 38.8
| 2.05
| 757
| 1.02
| 26.6
| 2.3
| 9.5
| 13.6
| 18.6
| 32.4
| 46.8
| 10.4
| 7.9
| 5.2
|
imp_268393
|
p16546003
| 15.5
|
Very High
|
[
"files/p16546003/p165460039789/s87169073/",
"files/p16546003/p165460037412/s46375503/"
] |
[
"p1654/p16546003/s42101542",
"p1654/p16546003/s43417701",
"p1654/p16546003/s43671561"
] |
Patient p16546003 is a 71-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 71
|
M
| 0
| 1
| 1
| 1
| 0
| 21.2
| 140.9
| 1
| 133
| 62
| 89
| 19
| 37.9
| 3.14
| 4,868
| 1.54
| 20.4
| 2.7
| 23.8
| 37.4
| 5.4
| 18.7
| 29.8
| 13.4
| 9.4
| 1.7
|
imp_319551
|
p16546005
| 19
|
Very High
|
[
"files/p16546005/p165460059442/s53562684/"
] |
[
"p1654/p16546005/s40556146",
"p1654/p16546005/s41790162",
"p1654/p16546005/s48391633"
] |
Patient p16546005 is a 51-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 51
|
M
| 1
| 0
| 1
| 1
| 1
| 69.3
| 465.9
| 0
| 129
| 106
| 73
| 12
| 38.7
| 4.95
| 222
| 2.9
| 45.1
| 2.6
| 15.6
| 19.8
| 12.8
| 23.5
| 24.1
| 34.8
| 8
| 1.3
|
imp_685606
|
p16546211
| 15
|
Very High
|
[
"files/p16546211/p165462115412/s69568885/",
"files/p16546211/p165462117337/s86150979/"
] |
[
"p1654/p16546211/s40578696",
"p1654/p16546211/s40943727",
"p1654/p16546211/s43634954",
"p1654/p16546211/s44473671"
] |
Patient p16546211 is a 28-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 28
|
M
| 1
| 1
| 1
| 1
| 0
| 22.5
| 398.5
| 0
| 123
| 71
| 52
| 21
| 37.6
| 1.46
| 579
| 1.71
| 21.6
| 2.5
| 10.1
| 9.6
| 3.7
| 14
| 16.9
| 2.5
| 1.6
| 1.4
|
imp_908251
|
p16546225
| 13.5
|
Very High
|
[
"files/p16546225/p165462254955/s82689185/"
] |
[
"p1654/p16546225/s40629558",
"p1654/p16546225/s49145595"
] |
Patient p16546225 is a 33-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 33
|
M
| 0
| 1
| 1
| 1
| 0
| 19.8
| 170.8
| 0
| 145
| 86
| 71
| 17
| 36.9
| 3.62
| 2,636
| 2.44
| 42.9
| 2.6
| 14
| 42.4
| 2.6
| 19.4
| 43.3
| 21.6
| 16.2
| 6.3
|
imp_673862
|
p16546275
| 11
|
High
|
[
"files/p16546275/p165462758287/s93335181/"
] |
[
"p1654/p16546275/s40527776",
"p1654/p16546275/s44409918",
"p1654/p16546275/s47747826",
"p1654/p16546275/s48454872",
"p1654/p16546275/s48727112",
"p1654/p16546275/s48789379",
"p1654/p16546275/s49430557"
] |
Patient p16546275 is a 48-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Multiple significant cardiac risk factors present. Baseline assessment shows concerning abnormalities. High risk for treatment-related cardiotoxicity. Consider cardioprotective strategies.
| 48
|
F
| 0
| 0
| 0
| 0
| 0
| 69.5
| 293.7
| 0
| 103
| 94
| 90
| 21
| 38.3
| 2.73
| 4,267
| 0.82
| 46.5
| 2.2
| 23.1
| 12.3
| 7.4
| 9.5
| 15.2
| 13.5
| 8.7
| 13.5
|
imp_779778
|
p16546330
| 12
|
Very High
|
[
"files/p16546330/p165463307471/s37022137/"
] |
[
"p1654/p16546330/s40196121",
"p1654/p16546330/s40652385",
"p1654/p16546330/s41129523",
"p1654/p16546330/s41360030",
"p1654/p16546330/s42140352",
"p1654/p16546330/s42174006",
"p1654/p16546330/s42269388",
"p1654/p16546330/s42465583",
"p1654/p16546330/s42776802",
"p1654/p16546330/s42786258",
"p1654/p16546330/s43213018",
"p1654/p16546330/s43455975",
"p1654/p16546330/s43499760",
"p1654/p16546330/s43528783",
"p1654/p16546330/s43844284",
"p1654/p16546330/s44527109",
"p1654/p16546330/s45790413",
"p1654/p16546330/s45908528",
"p1654/p16546330/s46168114",
"p1654/p16546330/s46468671",
"p1654/p16546330/s47507734",
"p1654/p16546330/s47519602",
"p1654/p16546330/s48048324",
"p1654/p16546330/s48418473",
"p1654/p16546330/s49455160",
"p1654/p16546330/s49537600",
"p1654/p16546330/s49934642"
] |
Patient p16546330 is a 64-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 64
|
M
| 0
| 0
| 0
| 0
| 1
| 8.5
| 261.8
| 1
| 145
| 68
| 95
| 19
| 36.3
| 4.66
| 2,081
| 0.63
| 55
| 2.7
| 15.4
| 30.1
| 18.7
| 12
| 28.8
| 4.8
| 23.6
| 10.4
|
imp_437516
|
p16546422
| 17.5
|
Very High
|
[
"files/p16546422/p165464229896/s16804206/"
] |
[
"p1654/p16546422/s42584139"
] |
Patient p16546422 is a 85-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 85
|
M
| 1
| 1
| 1
| 1
| 0
| 13.3
| 90.5
| 1
| 129
| 86
| 58
| 21
| 38.6
| 3.43
| 1,147
| 2.72
| 53.4
| 1.9
| 22.6
| 21.8
| 2.3
| 7.5
| 25.8
| 36.5
| 13.8
| 1.5
|
imp_876685
|
p16546656
| 24
|
Very High
|
[
"files/p16546656/p165466563305/s87031592/"
] |
[
"p1654/p16546656/s42037000",
"p1654/p16546656/s42441761",
"p1654/p16546656/s42635779"
] |
Patient p16546656 is a 93-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 93
|
F
| 1
| 1
| 0
| 1
| 1
| 63.5
| 249.8
| 1
| 178
| 65
| 108
| 15
| 37.4
| 4.3
| 3,487
| 2.28
| 17.7
| 2.5
| 19.4
| 30.5
| 3
| 28.3
| 48.7
| 29
| 7.1
| 5.8
|
imp_520815
|
p16549147
| 15.5
|
Very High
|
[
"files/p16549147/p165491477294/s21230536/",
"files/p16549147/p165491473169/s63791255/"
] |
[
"p1654/p16549147/s44082514"
] |
Patient p16549147 is a 39-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 39
|
M
| 1
| 1
| 1
| 0
| 0
| 12.1
| 391.6
| 1
| 147
| 80
| 53
| 23
| 36.8
| 3.63
| 3,399
| 1.14
| 29.1
| 2.5
| 15
| 22.6
| 13.2
| 13.7
| 28.1
| 8.2
| 18.9
| 14.8
|
imp_889912
|
p16546662
| 17
|
Very High
|
[
"files/p16546662/p165466627859/s23281710/"
] |
[
"p1654/p16546662/s40349082",
"p1654/p16546662/s40478877",
"p1654/p16546662/s40504166",
"p1654/p16546662/s40958344",
"p1654/p16546662/s42154110",
"p1654/p16546662/s42173624",
"p1654/p16546662/s42320889",
"p1654/p16546662/s42942533",
"p1654/p16546662/s43542263",
"p1654/p16546662/s43588701",
"p1654/p16546662/s43874421",
"p1654/p16546662/s43973960",
"p1654/p16546662/s44098130",
"p1654/p16546662/s44130357",
"p1654/p16546662/s44944476",
"p1654/p16546662/s45071331",
"p1654/p16546662/s45180495",
"p1654/p16546662/s45748921",
"p1654/p16546662/s45933642",
"p1654/p16546662/s46966277",
"p1654/p16546662/s47880838",
"p1654/p16546662/s47941881",
"p1654/p16546662/s48323131",
"p1654/p16546662/s49648997",
"p1654/p16546662/s49980021"
] |
Patient p16546662 is a 79-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 79
|
F
| 1
| 1
| 1
| 0
| 0
| 34.4
| 350.8
| 0
| 135
| 71
| 92
| 16
| 36.1
| 0.18
| 4,816
| 0.84
| 65.9
| 2.7
| 16.7
| 17.1
| 18.1
| 25.8
| 11.8
| 31.4
| 7.2
| 9.2
|
imp_465469
|
p16546690
| 13
|
Very High
|
[
"files/p16546690/p165466906220/s57825619/",
"files/p16546690/p165466909299/s70346785/"
] |
[
"p1654/p16546690/s45181401",
"p1654/p16546690/s47660896"
] |
Patient p16546690 is a 18-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 18
|
M
| 0
| 1
| 1
| 0
| 0
| 2
| 225.5
| 1
| 180
| 65
| 112
| 20
| 36.8
| 4.02
| 4,776
| 0.55
| 45.9
| 2.5
| 22
| 26.1
| 10.2
| 7.7
| 51.4
| 16.9
| 7
| 8.2
|
imp_918904
|
p16546768
| 15.5
|
Very High
|
[
"files/p16546768/p165467686415/s47283410/",
"files/p16546768/p165467689564/s77009843/"
] |
[
"p1654/p16546768/s41519683",
"p1654/p16546768/s43101503",
"p1654/p16546768/s45535293"
] |
Patient p16546768 is a 20-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 20
|
F
| 1
| 1
| 0
| 1
| 0
| 48
| 91
| 0
| 101
| 90
| 56
| 18
| 38.8
| 4.53
| 1,049
| 2.29
| 51.4
| 2.2
| 13.4
| 17.1
| 8.8
| 12.2
| 33.8
| 18.1
| 14.4
| 3.4
|
imp_955081
|
p16546851
| 13
|
Very High
|
[
"files/p16546851/p165468516370/s53281687/",
"files/p16546851/p165468519086/s58113555/"
] |
[
"p1654/p16546851/s45560874"
] |
Patient p16546851 is a 66-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 66
|
F
| 1
| 0
| 1
| 0
| 0
| 5.4
| 4.7
| 0
| 180
| 101
| 74
| 20
| 36.4
| 2.57
| 3,359
| 0.84
| 21
| 2.8
| 16.8
| 13.9
| 16.7
| 14.4
| 47.3
| 35.5
| 24.5
| 10.6
|
imp_280415
|
p16546907
| 18
|
Very High
|
[
"files/p16546907/p165469073820/s23405143/",
"files/p16546907/p165469078704/s44194073/"
] |
[
"p1654/p16546907/s48402651"
] |
Patient p16546907 is a 94-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 94
|
M
| 1
| 0
| 0
| 1
| 1
| 15.9
| 306.2
| 0
| 114
| 101
| 91
| 15
| 36.5
| 0.74
| 4,925
| 1.06
| 69.1
| 2.9
| 22.5
| 40.8
| 5.6
| 31.5
| 53.3
| 25.5
| 11.3
| 12.8
|
imp_985752
|
p16547007
| 14.5
|
Very High
|
[
"files/p16547007/p165470071093/s46855808/",
"files/p16547007/p165470071856/s10919202/"
] |
[
"p1654/p16547007/s47561322",
"p1654/p16547007/s49229653"
] |
Patient p16547007 is a 89-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 89
|
M
| 0
| 1
| 1
| 0
| 0
| 6.2
| 126.5
| 1
| 133
| 105
| 120
| 16
| 39
| 3.35
| 2,409
| 0.65
| 60
| 2.4
| 13.3
| 12
| 12.7
| 30.2
| 48.3
| 36.9
| 13.6
| 4.5
|
imp_624116
|
p16547190
| 20.5
|
Very High
|
[
"files/p16547190/p165471908313/s80299876/",
"files/p16547190/p165471909536/s55309017/"
] |
[
"p1654/p16547190/s42679309",
"p1654/p16547190/s43360556",
"p1654/p16547190/s44485254",
"p1654/p16547190/s45302240",
"p1654/p16547190/s47399502",
"p1654/p16547190/s47534166",
"p1654/p16547190/s47665963",
"p1654/p16547190/s47738986",
"p1654/p16547190/s47954611",
"p1654/p16547190/s48494029"
] |
Patient p16547190 is a 37-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 37
|
M
| 1
| 0
| 1
| 1
| 1
| 68
| 464.2
| 1
| 119
| 87
| 105
| 14
| 36.8
| 2.13
| 1,479
| 1.58
| 57.1
| 2.5
| 8.3
| 18.6
| 18.3
| 21.9
| 22.3
| 15.8
| 1.4
| 1.3
|
imp_998258
|
p16547245
| 12
|
Very High
|
[
"files/p16547245/p165472453175/s81263504/",
"files/p16547245/p165472451941/s49080194/"
] |
[
"p1654/p16547245/s41763829",
"p1654/p16547245/s45849670"
] |
Patient p16547245 is a 29-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 29
|
F
| 0
| 1
| 1
| 0
| 1
| 37.4
| 64.8
| 0
| 165
| 82
| 82
| 23
| 36.8
| 0.31
| 2,166
| 0.82
| 63.7
| 2.3
| 15.1
| 22.9
| 4.8
| 3.6
| 25
| 28.3
| 12.2
| 8.8
|
imp_193186
|
p16547377
| 15
|
Very High
|
[
"files/p16547377/p165473777794/s19568531/",
"files/p16547377/p165473776781/s61353651/"
] |
[
"p1654/p16547377/s42846670",
"p1654/p16547377/s43215179",
"p1654/p16547377/s44878848",
"p1654/p16547377/s45512304",
"p1654/p16547377/s49036382",
"p1654/p16547377/s49433919"
] |
Patient p16547377 is a 94-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 94
|
F
| 0
| 0
| 0
| 0
| 0
| 21.1
| 504
| 0
| 110
| 83
| 101
| 24
| 36.5
| 3.07
| 3,187
| 2.49
| 65.5
| 2.2
| 22.8
| 6.9
| 8.5
| 30.7
| 54.6
| 15.2
| 19
| 2.7
|
imp_449976
|
p16547446
| 15
|
Very High
|
[
"files/p16547446/p165474462745/s53633661/",
"files/p16547446/p165474463869/s30656947/"
] |
[
"p1654/p16547446/s42900516",
"p1654/p16547446/s47515771",
"p1654/p16547446/s49759219"
] |
Patient p16547446 is a 37-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 37
|
F
| 1
| 0
| 1
| 0
| 0
| 68.5
| 81.7
| 0
| 140
| 91
| 88
| 15
| 36.8
| 4.53
| 4,863
| 1.93
| 29.2
| 2.5
| 2.2
| 36.7
| 10.4
| 11.5
| 55.9
| 28.8
| 11.6
| 2.5
|
imp_468893
|
p16547560
| 21.5
|
Very High
|
[
"files/p16547560/p165475605260/s50605773/",
"files/p16547560/p165475609393/s19222246/"
] |
[
"p1654/p16547560/s43956977",
"p1654/p16547560/s45452779"
] |
Patient p16547560 is a 95-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 95
|
F
| 1
| 0
| 1
| 0
| 0
| 58.4
| 542.8
| 0
| 165
| 92
| 96
| 17
| 37.7
| 0.73
| 3,038
| 2.38
| 24
| 2.5
| 20.8
| 27
| 3
| 11.7
| 40.9
| 24.1
| 7
| 1.2
|
imp_746345
|
p16547583
| 17
|
Very High
|
[
"files/p16547583/p165475838738/s92090561/",
"files/p16547583/p165475831080/s49742688/",
"files/p16547583/p165475834304/s29289811/"
] |
[
"p1654/p16547583/s42923349",
"p1654/p16547583/s44499254",
"p1654/p16547583/s45172884",
"p1654/p16547583/s49807199"
] |
Patient p16547583 is a 25-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 25
|
M
| 1
| 0
| 1
| 1
| 0
| 51.4
| 234.7
| 0
| 148
| 82
| 80
| 15
| 37.4
| 3.45
| 4,873
| 2.46
| 22.6
| 2.1
| 19.1
| 19.3
| 10.8
| 16.6
| 11.9
| 29
| 18.8
| 1.8
|
imp_664380
|
p16547674
| 21
|
Very High
|
[
"files/p16547674/p165476747660/s81039251/"
] |
[
"p1654/p16547674/s41185986",
"p1654/p16547674/s45822399",
"p1654/p16547674/s46182563",
"p1654/p16547674/s46320718"
] |
Patient p16547674 is a 37-year-old male presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 37
|
M
| 1
| 1
| 1
| 0
| 1
| 43.2
| 463.8
| 1
| 93
| 98
| 98
| 15
| 38.7
| 2.34
| 4,771
| 2.69
| 22.2
| 2.7
| 13.4
| 25.2
| 5.2
| 11.3
| 39
| 24.1
| 16.6
| 8.8
|
imp_875798
|
p16547780
| 17
|
Very High
|
[
"files/p16547780/p165477801278/s67149990/",
"files/p16547780/p165477804823/s78794462/",
"files/p16547780/p165477808699/s52718471/"
] |
[
"p1654/p16547780/s40759251",
"p1654/p16547780/s40834345",
"p1654/p16547780/s42422538",
"p1654/p16547780/s42609836",
"p1654/p16547780/s43615810",
"p1654/p16547780/s44355094",
"p1654/p16547780/s44671787",
"p1654/p16547780/s45674616",
"p1654/p16547780/s46932220",
"p1654/p16547780/s47136386",
"p1654/p16547780/s47276816",
"p1654/p16547780/s47308554",
"p1654/p16547780/s49002755",
"p1654/p16547780/s49347518"
] |
Patient p16547780 is a 54-year-old female presenting for cardiac assessment. History of cancer treatment with potential cardiotoxic agents. Baseline cardiac function assessment prior to treatment initiation. Monitoring for treatment-related cardiac complications. Critical cardiac risk factors identified. Baseline assessment shows severe abnormalities. Very high risk for treatment-related cardiotoxicity. Immediate cardioprotective intervention recommended. Consider treatment modification or delay.
| 54
|
F
| 1
| 0
| 1
| 0
| 0
| 15.4
| 304.6
| 1
| 139
| 89
| 63
| 20
| 36.9
| 1.04
| 1,925
| 2.82
| 67.2
| 1.9
| 19.1
| 40.2
| 7.4
| 9.6
| 9.3
| 27.1
| 23.8
| 0.8
|
README.md exists but content is empty.
- Downloads last month
- 6